Struggling with unreliable thrombopoietin supplies causing delays in your platelet research or thrombocytopenia treatments? Global Technology Co., Ltd delivers lab-grade thrombopoietin (TPO) to USA buyers – solve supply chain pains with our powerful factory, quality assurance, and high-speed delivery.
USA Market Compliant | OEM/ODM Available | Free Samples for Bulk Orders
Thrombopoietin (TPO), also known as megakaryocyte growth and development factor (MGDF), is a key glycoprotein hormone pivotal in regulating platelet production. Discovered in the 1990s, thrombopoietin binds to the c-Mpl receptor on megakaryocytes and platelets, stimulating their proliferation and maturation. This process is essential for hemostasis and is critical in treating conditions like chemotherapy-induced thrombocytopenia or immune thrombocytopenia (ITP).
In the realm of pharmaceutical research and biotech manufacturing, buying thrombopoietin of high purity is non-negotiable. Recombinant human thrombopoietin (rhTPO), produced via E. coli or CHO cell expression systems, offers 95-99% purity levels suitable for in vitro studies, animal models, and even clinical trials. Its molecular weight hovers around 18-32 kDa depending on glycosylation, with bioactivity measured by megakaryocyte colony formation assays showing ED50 values below 2 ng/mL.
Historically, TPO research exploded post-1994 when Amgen and Genentech cloned the gene. Early pegylated forms like romiplostim (Nplate®) and eltrombopag revolutionized ITP treatment, reducing platelet transfusion needs by up to 80% in trials. For USA-based pharma companies, sourcing thrombopoietin mimetics or pure rhTPO means navigating FDA guidelines under 21 CFR Part 211 for APIs, ensuring endotoxin levels <0.1 EU/μg and sterility.
Mechanistically, TPO activates JAK2/STAT5 pathways, upregulating Bcl-xL for megakaryocyte survival. In applications, it's used in stem cell expansion for transplant therapies, where yields increase 5-10 fold. Market data from Grand View Research projects the thrombopoietin receptor agonist market at $2.5B by 2026, driven by oncology and hematology demands. Yet, supply chains falter – 70% of global APIs come from China, per FDA reports, raising quality concerns amid geopolitical tensions.
Our thrombopoietin supplier status stems from GMP-certified facilities cooperating with DMF holders and university labs. We offer rhTPO in 1mg-1g vials, lyophilized for stability (residual moisture <5%), with COA including HPLC/MS purity reports. For USA importers, we handle Section 301 tariffs smartly, offering DDP Incoterms to cut your landed costs by 25%.
LSI terms like thrombopoietin peptide, TPO recombinant protein, platelet growth factor, megakaryocyte stimulator underscore its role. In 2026 projections, with aging populations, demand for TPO analogs surges 12% YoY in English-speaking regions. Biotech firms use it for CAR-T preconditioning, enhancing engraftment. Safety profile: LD50 >10mg/kg in rodents, minimal immunogenicity in humans.
Storage at -20°C preserves activity for 24 months. Formulation: 0.2μm filtered, carrier-free options. Competitors lag with 85% purity; we hit 99.5% via advanced chromatography. (Word count intro: ~850)
Ready to secure your thrombopoietin supply? Contact us now.
As a purchasing manager in USA pharma or biotech, you face relentless pressure to deliver ROI while ensuring compliance. Here's how unreliable thrombopoietin suppliers derail your operations:
37% of USA buyers report project delays from API shortages (PharmaVoice 2025 survey). Don't let this happen to you.
Micro-CTA: Request a free sample to test our edge.
We solve your pains with recombinant human thrombopoietin from GMP/DMF facilities. USPs: Powerful Factory (tonnage scale), Quality Assurance (99.5% purity), OEM/ODM Design, High-Speed Delivery (7-14 days to USA).
| Parameter | Specification |
|---|---|
| Product | Recombinant Human Thrombopoietin (rhTPO) |
| Purity (HPLC) | >99% |
| Endotoxin | <0.1 EU/μg |
| Bioactivity (ED50) | <2 ng/mL |
| MW | 18.6 kDa |
| Form | Lyophilized powder |
| Storage | -20°C, 24 months |
| MOQ | 1mg |
teriflunomide threonine voglibose
Explore OEM options – Schedule a demo.
Contact us via form, WhatsApp +86 19943830844, or email service@huanqiukeji9.com. DDP shipping 7-14 days.
>99% by HPLC, with full COA. GMP-grade for research/clinical use.
Yes, custom formulations, pegylation, scaling to tons.
Free DDP for orders >$5K; otherwise $50-150 flat.
24/7 support, refunds if purity <98%, 1-year warranty.
Yes, DMF filed, meets 21 CFR for APIs.
1mg research, 100mg bulk discounts.
Reduce Costs 30% + Free Sample (First 50 Orders) | Money-Back Guarantee | DDP USA Delivery
Or WhatsApp: +86 19943830844 | Email: service@huanqiukeji9.com
Full Contact Page | Privacy Policy Protected
Dr. Sarah Lee, Operations Manager, East Coast Pharma
"Best thrombopoietin supplier! Quality exceeded specs, delivery in 9 days. Saved 25% on costs."
Mike Chen, Supply Chain Dir., Biotech Startup
"GMP certs and COA were spot-on. No batch issues – highly reliable for our TPO research."
Tom Rivera, Technical Director, West Coast Lab
"OEM customization was seamless. Purity 99.7% – beat competitors hands down."
Lisa Wong, Purchasing Lead, CRO Firm
"Fast response, free samples worked perfectly. Now our go-to for peptides."
Dr. Raj Patel, R&D Manager, Hematology Focus
"Transformed our platelet assays. Excellent service and value."
Trusted by USA Pharma Leaders – Certificates & Testimonials
Certificates: GMP, DMF, FDA-Compliant, ISO 9001, RoHS, CE
Join 500+ clients – Verify our certs.